https://www.selleckchem.com/pr....oducts/cx-4945-silmi
MIDs for improvement (deterioration) ranged from 6 to 18 (-11 to -5) points for within-group change and 5 to 15 (-10 to -4) for between-group change. Summarized MIDs (in absolute values) per scale mostly ranged from 5 to 10 points. These findings have clinical relevance for the interpretation of treatment efficacy and the design of clinical trials by informing sample size requirements. These findings have clinical relevance for the interpretation of treatment efficacy and the design of clinical trials by informing sample s